Pharma & Biotech
Acasti Pharma edging closer to commercializing CaPre as it eyes topline clinical data for Christmas
ImmunoPrecise Antibodies expecting significant revenue growth in 2019
TIMIA Capital's revenue-based financing aims to lever up tech entrepreneurs
Only registered members can use this feature.
Copyright © Proactive Investors 2019.
All Rights Reserved - Proactive Investors North America Inc., Proactive Investors LLC.